Hieken, T. J., Egger, M. E., Angeles, C. V., Hyngstrom, J. R., Burke, E. E., Lowe, M. C., … Sondak, V. K. (2025). Prospective multicenter evaluation (MERLIN 001 trial, NCT04759781) of a clinicopathologic and gene expression profile test to predict sentinel node status in T1-T3 NO melanoma. In ANNALS OF SURGICAL ONCOLOGY (Vol. 32, pp. S33–S34).

Hieken, Tina J., Michael E. Egger, Christina V. Angeles, John R. Hyngstrom, Erin E. Burke, Michael C. Lowe, Georgia M. Beasley, et al. “Prospective multicenter evaluation (MERLIN 001 trial, NCT04759781) of a clinicopathologic and gene expression profile test to predict sentinel node status in T1-T3 NO melanoma.” In ANNALS OF SURGICAL ONCOLOGY, 32:S33–34, 2025.

Hieken TJ, Egger ME, Angeles CV, Hyngstrom JR, Burke EE, Lowe MC, et al. Prospective multicenter evaluation (MERLIN 001 trial, NCT04759781) of a clinicopathologic and gene expression profile test to predict sentinel node status in T1-T3 NO melanoma. In: ANNALS OF SURGICAL ONCOLOGY. 2025. p. S33–4.

Hieken, Tina J., et al. “Prospective multicenter evaluation (MERLIN 001 trial, NCT04759781) of a clinicopathologic and gene expression profile test to predict sentinel node status in T1-T3 NO melanoma.” ANNALS OF SURGICAL ONCOLOGY, vol. 32, 2025, pp. S33–34.

Hieken TJ, Egger ME, Angeles CV, Hyngstrom JR, Burke EE, Lowe MC, Beasley GM, Bartlett EK, Md SCB, Harms KL, Zager J, Md NW, Bagaria S, McMasters KM, Wada DA, Pandalai PK, Delman KA, Lee JS, Busam KJ, Sondak VK. Prospective multicenter evaluation (MERLIN 001 trial, NCT04759781) of a clinicopathologic and gene expression profile test to predict sentinel node status in T1-T3 NO melanoma. ANNALS OF SURGICAL ONCOLOGY. 2025. p. S33–S34.